Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01073982 · ClinicalTrials.gov registry record · Phase 4

Efficacy of Tart Cherry Juice to Reduce Pain and Inflammation Among Patients With Inflammatory Osteoarthritis

A Phase 4 study, sponsored by Oregon Health and Science University.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target

NCT01073982: Completed Phase 4 study, sponsored by Oregon Health and Science University.

NCT01073982 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01073982, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to assess the effects of tart cherry juice to reduce pain and inflammation among individuals with arthritis.

Interventions

  • DIETARY_SUPPLEMENT tart cultivar Montmorency cherry juice

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-02
Est. Completion 2011-01
Phase Phase 4

What the finished NCT01073982 record still lists

NCT01073982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which tart cultivar Montmorency cherry juice is the first listed.

NCT01073982 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01073982 about?

NCT01073982 is a clinical study titled "Efficacy of Tart Cherry Juice to Reduce Pain and Inflammation Among Patients With Inflammatory Osteoarthritis". The purpose of this study is to assess the effects of tart cherry juice to reduce pain and inflammation among individuals with arthritis.

What is the current status of trial NCT01073982?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-02. Estimated completion is 2011-01.

What interventions are being tested in trial NCT01073982?

The interventions under investigation include: tart cultivar Montmorency cherry juice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01073982?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01073982's enrollment target sits among peer trials

20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01073982, the US trial registry maintained by the National Library of Medicine. NCT01073982 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.